Symbols / NMTC
NMTC Chart
About
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 35.14M |
| Enterprise Value | 31.88M | Income | -6.83M | Sales | 11.72M |
| Book/sh | 0.13 | Cash/sh | 0.07 | Dividend Yield | — |
| Payout | 0.00% | Employees | 18 | IPO | — |
| P/E | — | Forward P/E | -2.49 | PEG | — |
| P/S | 3.00 | P/B | 5.49 | P/C | — |
| EV/EBITDA | -4.32 | EV/Sales | 2.72 | Quick Ratio | 4.95 |
| Current Ratio | 6.41 | Debt/Eq | 3.71 | LT Debt/Eq | — |
| EPS (ttm) | -0.09 | EPS next Y | -0.28 | EPS Growth | — |
| Revenue Growth | -11.70% | Earnings | 2026-05-12 | ROA | -63.40% |
| ROE | -146.27% | ROIC | — | Gross Margin | 22.03% |
| Oper. Margin | -59.02% | Profit Margin | -58.28% | Shs Outstand | 50.43M |
| Shs Float | 47.58M | Short Float | 0.16% | Short Ratio | 0.22 |
| Short Interest | — | 52W High | 1.18 | 52W Low | 0.40 |
| Beta | 0.62 | Avg Volume | 292.89K | Volume | 42.46K |
| Target Price | $2.30 | Recom | Strong_buy | Prev Close | $0.68 |
| Price | $0.70 | Change | 2.47% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$2.30
Mean price target
2. Current target
$0.70
Latest analyst target
3. DCF / Fair value
$-1.40
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.70
Low
$1.60
High
$3.00
Mean
$2.30
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-09-09 | init | Maxim Group | — → Buy | $3 |
| 2025-05-05 | init | Ladenburg Thalmann | — → Buy | $1 |
| 2023-08-15 | main | Alliance Global Partners | Buy → Buy | $2 |
| 2022-03-28 | down | Craig-Hallum | Buy → Hold | — |
| 2021-12-03 | init | Alliance Global Partners | — → Buy | $6 |
| 2021-11-15 | init | Craig-Hallum | — → Buy | $6 |
- $NMTC ($NMTC) Releases Q1 2026 Earnings - Quiver Quantitative ue, 17 Feb 2026 12
- We're Hopeful That NeuroOne Medical Technologies (NASDAQ:NMTC) Will Use Its Cash Wisely - Yahoo Finance hu, 06 Nov 2025 08
- NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment - Zacks Investment Research ue, 19 Aug 2025 07
- With NeuroOne Medical Technologies Stock Surging, Have You Considered The Downside? - Trefis Fri, 19 Dec 2025 08
- NeuroOne Medical Technologies (NASDAQ:NMTC) Is In A Good Position To Deliver On Growth Plans - simplywall.st hu, 11 Dec 2025 08
- NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment - Nasdaq ue, 19 Aug 2025 07
- NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Update - 富途牛牛 Sat, 14 Feb 2026 07
- NeuroOne (NMTC) Q1 2026 Earnings Call Transcript - The Globe and Mail ue, 17 Feb 2026 08
- Earnings call transcript: NeuroOne Medical beats Q1 2026 EPS forecast, stock dips - Investing.com ue, 17 Feb 2026 14
- NeuroOne Medical Technologies Corp (NMTC) Q1 2026: Everything Yo - GuruFocus Mon, 16 Feb 2026 12
- $NMTC Earnings Preview: Recent $NMTC Insider Trading, Hedge Fund Activity, and More | NMTC Stock News - Quiver Quantitative Mon, 08 Dec 2025 08
- NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-K Report - TradingView Wed, 17 Dec 2025 08
- Earnings To Watch: NeuroOne Medical Technologies Corp (NMTC) Reports Q4 2025 Result - Yahoo Finance ue, 16 Dec 2025 08
- Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises - Investing.com Wed, 17 Dec 2025 08
- Insider Buyers Lose US$21k As NeuroOne Medical Technologies Sheds US$6.2m - simplywall.st hu, 10 Apr 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 34020 | 1191.0 | — | Conversion of Exercise of derivative security at price 0.04 per share. | MATHIESEN JEFFREY S | Director | — | 2020-06-15 00:00:00 | D |
| 1 | 334000 | 524380.0 | — | Sale at price 1.57 per share. | CHRISTIANSON MARK | Officer | — | 2020-06-12 00:00:00 | D |
| 2 | 22371 | — | — | Stock Award(Grant) at price 0.00 per share. | MATHIESEN JEFFREY S | Director | — | 2020-06-02 00:00:00 | D |
| 3 | 22371 | — | — | Stock Award(Grant) at price 0.00 per share. | BUCKMAN PAUL R | Director | — | 2020-06-02 00:00:00 | D |
| 4 | 22371 | — | — | Stock Award(Grant) at price 0.00 per share. | ANDRLE EDWARD | Director | — | 2020-06-02 00:00:00 | D |
| 5 | 7064 | — | — | Stock Award(Grant) at price 0.00 per share. | ANDRLE EDWARD | Director | — | 2020-02-19 00:00:00 | D |
| 6 | 26261 | — | — | Stock Award(Grant) at price 0.00 per share. | MATHIESEN JEFFREY S | Director | — | 2020-02-10 00:00:00 | D |
| 7 | 44118 | — | — | Stock Award(Grant) at price 0.00 per share. | BUCKMAN PAUL R | Director | — | 2020-02-10 00:00:00 | D |
| 8 | 14006 | — | — | Stock Award(Grant) at price 0.00 per share. | MATHIESEN JEFFREY S | Director | — | 2019-06-04 00:00:00 | D |
| 9 | 14006 | — | — | Stock Award(Grant) at price 0.00 per share. | BUCKMAN PAUL R | Director | — | 2019-06-04 00:00:00 | D |
Financials
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -3.79M | -11.52M | -11.66M | -9.91M |
| TotalUnusualItems | 784.67K | -327.09K | 1.97K | |
| TotalUnusualItemsExcludingGoodwill | 784.67K | -327.09K | 1.97K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -3.61M | -12.32M | -11.86M | -10.00M |
| ReconciledDepreciation | 261.68K | 246.79K | 199.27K | 118.62K |
| ReconciledCostOfRevenue | 3.96M | 2.37M | 1.50M | 241.96K |
| EBITDA | -3.01M | -11.84M | -11.66M | -9.91M |
| EBIT | -3.27M | -12.09M | -11.86M | -10.03M |
| NetInterestIncome | -334.06K | -228.99K | 0.00 | 0.00 |
| InterestExpense | 334.06K | 228.99K | 0.00 | 0.00 |
| NormalizedIncome | -4.39M | -11.99M | -11.86M | -10.00M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -3.61M | -12.32M | -11.86M | -10.00M |
| TotalExpenses | 13.32M | 15.34M | 13.91M | 10.20M |
| TotalOperatingIncomeAsReported | -4.23M | -11.89M | -11.96M | -10.03M |
| DilutedAverageShares | 26.76M | 18.12M | 16.00M | 10.70M |
| BasicAverageShares | 26.76M | 18.12M | 16.00M | 10.70M |
| DilutedEPS | -0.46 | -0.65 | -0.63 | -0.93 |
| BasicEPS | -0.46 | -0.65 | -0.63 | -0.93 |
| DilutedNIAvailtoComStockholders | -3.61M | -12.32M | -11.86M | -10.00M |
| NetIncomeCommonStockholders | -3.61M | -12.32M | -11.86M | -10.00M |
| NetIncome | -3.61M | -12.32M | -11.86M | -10.00M |
| NetIncomeIncludingNoncontrollingInterests | -3.61M | -12.32M | -11.86M | -10.00M |
| NetIncomeContinuousOperations | -3.61M | -12.32M | -11.86M | -10.00M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -3.61M | -12.32M | -11.86M | -10.00M |
| OtherIncomeExpense | 955.16K | -201.91K | 95.76K | 31.15K |
| OtherNonOperatingIncomeExpenses | 170.49K | 125.18K | 95.76K | 31.15K |
| SpecialIncomeCharges | 0.00 | |||
| GainOnSaleOfSecurity | 784.67K | -327.09K | 1.97K | |
| NetNonOperatingInterestIncomeExpense | -334.06K | -228.99K | 0.00 | 0.00 |
| InterestExpenseNonOperating | 334.06K | 228.99K | 0.00 | 0.00 |
| OperatingIncome | -4.23M | -11.89M | -11.96M | -10.03M |
| OperatingExpense | 9.37M | 12.97M | 12.41M | 9.96M |
| OtherOperatingExpenses | -3.00M | -1.46M | -1.95M | -64.81K |
| ResearchAndDevelopment | 4.98M | 5.07M | 6.94M | 4.93M |
| SellingGeneralAndAdministration | 7.38M | 7.90M | 6.93M | 6.98M |
| GeneralAndAdministrativeExpense | 6.26M | |||
| OtherGandA | 6.26M | |||
| GrossProfit | 5.14M | 1.08M | 456.52K | -70.79K |
| CostOfRevenue | 3.96M | 2.37M | 1.50M | 241.96K |
| TotalRevenue | 9.10M | 3.45M | 1.95M | 171.17K |
| OperatingRevenue | 9.10M | 3.45M | 1.95M | 171.17K |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| OrdinarySharesNumber | 50.01M | 30.82M | 23.93M | 16.22M |
| ShareIssued | 50.01M | 30.82M | 23.93M | 16.22M |
| TotalDebt | 266.81K | 260.16K | 184.40K | 202.90K |
| TangibleBookValue | 7.03M | 754.75K | 6.16M | 9.49M |
| InvestedCapital | 7.07M | 822.01K | 6.25M | 9.60M |
| WorkingCapital | 7.92M | 2.42M | 5.52M | 9.08M |
| NetTangibleAssets | 7.03M | 754.75K | 6.16M | 9.49M |
| CapitalLeaseObligations | 266.81K | 260.16K | 184.40K | 202.90K |
| CommonStockEquity | 7.07M | 822.01K | 6.25M | 9.60M |
| TotalCapitalization | 7.07M | 822.01K | 6.25M | 9.60M |
| TotalEquityGrossMinorityInterest | 7.07M | 822.01K | 6.25M | 9.60M |
| StockholdersEquity | 7.07M | 822.01K | 6.25M | 9.60M |
| RetainedEarnings | -78.61M | -75.00M | -62.69M | -50.83M |
| AdditionalPaidInCapital | 85.63M | 75.80M | 68.91M | 60.41M |
| CapitalStock | 50.01K | 30.82K | 23.93K | 16.22K |
| CommonStock | 50.01K | 30.82K | 23.93K | 16.22K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 3.71M | 4.55M | 1.85M | 3.22M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.41M | 2.33M | 55.28K | 119.56K |
| DerivativeProductLiabilities | 1.27M | 2.14M | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 143.15K | 194.39K | 55.28K | 119.56K |
| LongTermCapitalLeaseObligation | 143.15K | 194.39K | 55.28K | 119.56K |
| CurrentLiabilities | 2.30M | 2.21M | 1.79M | 3.10M |
| OtherCurrentLiabilities | 1.44K | 59.95K | 83.15K | |
| CurrentDeferredLiabilities | 0.00 | 1.46M | 8.62K | |
| CurrentDeferredRevenue | 0.00 | 1.46M | 8.62K | |
| CurrentDebtAndCapitalLeaseObligation | 123.66K | 65.77K | 129.12K | 83.34K |
| CurrentCapitalLeaseObligation | 123.66K | 65.77K | 129.12K | 83.34K |
| PayablesAndAccruedExpenses | 2.18M | 2.09M | 1.66M | 1.56M |
| CurrentAccruedExpenses | 1.17M | 1.06M | 978.41K | 632.50K |
| Payables | 1.01M | 1.03M | 685.10K | 927.66K |
| AccountsPayable | 1.01M | 1.03M | 685.10K | 927.66K |
| TotalAssets | 10.79M | 5.37M | 8.10M | 12.82M |
| TotalNonCurrentAssets | 559.36K | 739.01K | 784.39K | 646.85K |
| GoodwillAndOtherIntangibleAssets | 44.95K | 67.26K | 89.58K | 111.89K |
| NetPPE | 514.42K | 671.75K | 694.81K | 534.95K |
| AccumulatedDepreciation | -798.82K | -559.46K | -334.98K | -186.36K |
| GrossPPE | 1.31M | 1.23M | 1.03M | 721.31K |
| OtherProperties | 255.19K | 254.91K | 169.06K | 719.42K |
| MachineryFurnitureEquipment | 1.06M | 976.30K | 860.74K | 1.90K |
| CurrentAssets | 10.23M | 4.63M | 7.31M | 12.18M |
| CurrentDeferredAssets | 22.92K | 142.63K | 0.00 | 0.00 |
| PrepaidAssets | 141.37K | 216.46K | 263.75K | 296.65K |
| Inventory | 2.23M | 2.64M | 1.73M | 704.54K |
| OtherInventories | 871.49K | 877.07K | 1.20M | 400.06K |
| FinishedGoods | 1.23M | 1.57M | 180.31K | 73.97K |
| WorkInProcess | 130.10K | 192.36K | 343.60K | 230.51K |
| Receivables | 1.26M | 176.64K | 0.00 | 33.24K |
| AccountsReceivable | 1.26M | 176.64K | 0.00 | 33.24K |
| CashCashEquivalentsAndShortTermInvestments | 6.57M | 1.46M | 5.32M | 11.14M |
| OtherShortTermInvestments | 0.00 | 2.98M | 0.00 | |
| CashAndCashEquivalents | 6.57M | 1.46M | 5.32M | 8.16M |
| CashFinancial | 6.90M |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| FreeCashFlow | -2.92M | -11.13M | -13.27M | -7.79M |
| RepurchaseOfCapitalStock | -124.62K | -81.40K | -119.42K | 0.00 |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 9.61M | 5.87M | 8.59M | 13.35M |
| CapitalExpenditure | -81.74K | -120.20K | -384.12K | -275.23K |
| EndCashPosition | 6.57M | 1.46M | 5.32M | 8.16M |
| BeginningCashPosition | 1.46M | 5.32M | 8.16M | 6.90M |
| ChangesInCash | 5.11M | -3.86M | -2.84M | 1.26M |
| FinancingCashFlow | 8.03M | 7.27M | 7.40M | 12.02M |
| CashFlowFromContinuingFinancingActivities | 8.03M | 7.27M | 7.40M | 12.02M |
| NetOtherFinancingCharges | -1.53M | -332.92K | -1.07M | -1.33M |
| ProceedsFromStockOptionExercised | 69.75K | 1.81M | 0.00 | 0.00 |
| NetCommonStockIssuance | 9.49M | 5.79M | 8.47M | 13.35M |
| CommonStockPayments | -124.62K | -81.40K | -119.42K | 0.00 |
| CommonStockIssuance | 9.61M | 5.87M | 8.59M | 13.35M |
| NetIssuancePaymentsOfDebt | 0.00 | |||
| NetLongTermDebtIssuance | 0.00 | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -81.74K | -120.20K | 2.65M | -3.24M |
| CashFlowFromContinuingInvestingActivities | -81.74K | -120.20K | 2.65M | -3.24M |
| NetInvestmentPurchaseAndSale | 0.00 | 3.03M | -2.97M | 0.00 |
| SaleOfInvestment | 0.00 | 4.50M | 500.00K | 0.00 |
| PurchaseOfInvestment | 0.00 | -1.47M | -3.47M | 0.00 |
| NetPPEPurchaseAndSale | -81.74K | -120.20K | -376.62K | -275.23K |
| SaleOfPPE | 0.00 | 7.50K | 0.00 | |
| PurchaseOfPPE | -81.74K | -120.20K | -384.12K | -275.23K |
| OperatingCashFlow | -2.84M | -11.01M | -12.89M | -7.52M |
| CashFlowFromContinuingOperatingActivities | -2.84M | -11.01M | -12.89M | -7.52M |
| ChangeInWorkingCapital | -429.19K | -954.61K | -2.43M | 1.21M |
| ChangeInPayablesAndAccruedExpense | 185.54K | 83.21K | -1.47M | 1.95M |
| ChangeInAccruedExpense | -54.44K | 16.21K | -1.23M | 1.43M |
| ChangeInPayable | 239.98K | 66.99K | -247.19K | 515.44K |
| ChangeInAccountPayable | 239.98K | 66.99K | -247.19K | 515.44K |
| ChangeInPrepaidAssets | 75.09K | 47.28K | 32.90K | -145.54K |
| ChangeInInventory | 398.35K | -908.47K | -1.02M | -606.25K |
| ChangeInReceivables | -1.09M | -176.64K | 33.24K | 15.10K |
| ChangesInAccountReceivables | -1.09M | -176.64K | 33.24K | 15.10K |
| OtherNonCashItems | -338.99K | 669.61K | 109.83K | 212.16K |
| StockBasedCompensation | 1.26M | 1.34M | 1.11M | 947.21K |
| ProvisionandWriteOffofAssets | 10.00K | 0.00 | ||
| AmortizationOfSecurities | 0.00 | -45.57K | -11.47K | |
| DepreciationAmortizationDepletion | 261.68K | 246.79K | 199.27K | 118.62K |
| DepreciationAndAmortization | 261.68K | 246.79K | 199.27K | 118.62K |
| AmortizationCashFlow | 22.32K | 22.32K | 22.32K | 22.32K |
| AmortizationOfIntangibles | 22.32K | 22.32K | 22.32K | 22.32K |
| Depreciation | 239.36K | 224.48K | 176.95K | 96.31K |
| OperatingGainsLosses | 32.14K | -85.31K | ||
| GainLossOnInvestmentSecurities | -1.97K | |||
| GainLossOnSaleOfPPE | 0.00 | 32.14K | 0.00 | |
| NetIncomeFromContinuingOperations | -3.61M | -12.32M | -11.86M | -10.00M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NMTC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|